Tamoxifen in Treating Women With High-Risk Breast Cancer

NCT00002542 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

672

Enrollment

NETWORK

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: CMF regimen
DRUG: cyclophosphamide
DRUG: doxorubicin hydrochloride
DRUG: epirubicin hydrochloride
DRUG: fluorouracil
DRUG: methotrexate
DRUG: tamoxifen citrate
RADIATION: radiation therapy

Sponsor

NCIC Clinical Trials Group